Skip to content

Magnetic Resonance Imaging Using Innovative Pulse Sequences

Magnetic Resonance Imaging Using Innovative Pulse Sequences

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01724216
Enrollment
11
Registered
2012-11-09
Start date
2012-10-31
Completion date
2013-04-30
Last updated
2015-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Indication for a Head MRI

Brief summary

The purpose of the study is to collect in vivo human image data to demonstrate neurological magnetic resonance imaging (MRI) of subjects using short pulse sequences.

Detailed description

This is a single-site; open-label, prospective research Study involving human subjects. There will be no comparative efficacy or safety analysis and therefore no randomization

Interventions

Collect in vivo human data to demonstrate neurological Magnetic Resonance Imaging of subjects using a pulse sequence

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be at least 18 years of age * Subject must be willing and able to undergo verbal and written informed consent * Subject must have a clinical indication for a head MRI with and without Gadolinium-based contrast agent administration

Exclusion criteria

* Subjects who have any of the conditions below at the time of the enrollment or scan session are excluded from this study. Further, should it be determined by study staff that an enrolled subject meets any of the conditions below during the course of the study, the subject will be removed from the study. * Any contraindication to an MRI scan per the policy of Spectrum Health * Any contraindication to administration of an MRI contrast agent per the policy of Spectrum Health * Off-label utilization of contrast agents administered for the subject's clinical exam

Design outcomes

Primary

MeasureTime frameDescription
Number of Head Images Successfully Collected6-monthsCollect head human images and associated technical and clinical information to demonstrate neurological magnetic resonance imaging of subjects using short pulse sequence.

Countries

United States

Participant flow

Recruitment details

Subjects with orders from their doctor for an MRI were screened from Spectrum Health's Neurology Department. The study coordinator contacts each subject that met the inclusion criteria. If the subject is interested to volunteer, a copy of the Informed Consent was sent and appointment scheduled. Seg. 1 enrolled 11 subjects; no Seg. 2 enrollment.

Pre-assignment details

This is a single arm study.

Participants by arm

ArmCount
Single Arm
Magnetic Resonance Image Collection Using Innovative Pulse Sequences
10
Total10

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyScan was not completed1

Baseline characteristics

CharacteristicSingle Arm
Age, Customized
<=18 years
0 participants with images collected
Age, Customized
>=65 years
0 participants with images collected
Age, Customized
Between 18 and 65 years
10 participants with images collected
Region of Enrollment
United States
10 particpants with images collected
Sex/Gender, CustomizedNA participants with images collected

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 11
serious
Total, serious adverse events
0 / 11

Outcome results

Primary

Number of Head Images Successfully Collected

Collect head human images and associated technical and clinical information to demonstrate neurological magnetic resonance imaging of subjects using short pulse sequence.

Time frame: 6-months

ArmMeasureValue (NUMBER)
Single ArmNumber of Head Images Successfully Collected10 Images

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026